RxDoctor Payments Data

Ruben Diaz, MD

Physical Medicine & Rehabilitation · Savannah, GANPI 1194751024

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $943 of the $1,547 with a category attached, or 61.0%. 13 manufacturers reported payments, led by Medtronic at 47.0% of the total.

$1,547in general payments, 2019–2025

Across 46 payments — averaging $33.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$728
  • Boston Scientific$458
  • SPR Therapeutics, Inc$138
  • AbbVie$40
  • Avanos Medical$28
  • Amgen$27
  • plus $128 from 7 others

What the payments were for

  • Travel & lodging$60439%
  • Food & beverage$94361%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,547 in reported general payments places this provider in the 75th percentile of 214 physical medicine & rehabilitation providers in Georgia.

See all physical medicine & rehabilitation providers in Georgia

Medicare billing

Part B allowed, 2024
$61,169
Medicare patients
111
Services billed
848

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RelistorMethylnaltrexone Bromide12$28,848
LinzessLinaclotide29$17,540
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen126$3,443
Baclofen203$2,092
Naloxone Hcl28$1,946
Gabapentin133$1,415
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen53$1,263
Tramadol Hcl180$1,168
Pregabalin79$1,108
Tizanidine Hcl96$794
Diclofenac Sodium30$631
Etodolac14$454
Acetaminophen-CodeineAcetaminophen With Codeine26$402
Topiramate39$349
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen14$168

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$16$28,84812 claims
AbbVieLinzess$40$17,54029 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 214 physical medicine & rehabilitation providers in Georgia.

Other physical medicine & rehabilitation in Savannah

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →